VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMW 2019 | Off the shelf NK-cell MM therapy

Sarah Holstein, MD, PhD, University of Nebraska Medical Center, Omaha, NE, elaborates on placental derived natural killer (NK) cells (PNK007) and their integration into the post-melphalan transplantation period of multiple myeloma (MM). Dr Holstein goes on to lay out the next steps for PNK-cell therapy. This interview was recorded at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter